Since the 2018 law change legalising medical cannabis in the UK, the market has emerged as a prescription-led industry with strong regulatory oversight. This framework is fostering growth by building trust among healthcare professionals and patients alike
다만 금융사와 기술 회사들조차 암호화폐에 큰 관심을 두기 실시한 오늘날 시점에서는 '화폐'로 보기 힘들다는 의견이 지배적입니다. '전자화폐' 용도로 개발됐지만 현실 적으로는 '투자 제품'으로서의 가상 자산으로 평가받고 있는 겁니다.
Since the 2018 law change legalising medical cannabis in the UK, the market has evolved into a prescription-led industry with significant growth potential
Innovation is speeding ahead, often outpacing government rules designed to keep us safe. This leaves some grey-area products on the market without clear guidelines
Innovation is moving at pace, often outstripping regulation. This means some products land in grey areas without clear safety rules. For UK consumers, it’s important to stay informed, check independent reviews, and be cautious before buying
Since the 2018 law change legalising medical cannabis in the UK, the market has evolved as a prescription-led industry. Regulation plays a key role in building trust among healthcare professionals and patients, shaping growth opportunities
Since the 2018 law reform legalised medical cannabis prescriptions in the UK, the market has evolved into a tightly regulated, prescription-led sector
Innovation is speeding ahead, often leaving regulations struggling to keep up. This means some new products fall into grey areas, raising questions about consumer safety
Innovation is speeding ahead of the rules meant to keep us safe, especially with grey-area products that don’t yet fit clear regulations. This can leave consumers unsure about safety and quality
Since the 2018 law change legalising medical cannabis in the UK, the market has evolved into a prescription-led industry with significant growth potential